Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Prof Habib addresses inequality at public lecture
2014-08-06

 
One of South Africa’s leading political commentators, Prof Adam Habib, gave a public lecture and launched his latest book on the Bloemfontein Campus on Wednesday 30 July 2014. The event was hosted by the Department of Philosophy in association with Wits University Press and The Southern African Trust.

Prof Habib started his lecture by summarising his book, ‘South Africa’s Suspended Revolution: Hopes and Prospects’. “It is basically about: how did we get where we are today, and how do we get out of the mess we are in?” he said.

His book focuses on South Africa’s transition into democracy and the country’s prospects for inclusive development – which formed the basis of his talk. Prof Habib stressed the issue of inequality facing South Africa and discussed the different approaches to addressing the matter.

“The one approach is that it is simply something we have to live with,” he said. “People who believe this live in a bubble. For example, service delivery protests do not happen because of poverty – it happens because of inequality.”

Prof Habib cautioned against not taking the matter seriously. “Inequality went up consistently in South Africa over the last 20 years. This is however not solely a national challenge, but a global challenge. And South Africa is the frontline of the war on inequality.”

He proposed that the expectations of the rich, rather than the poor, should be addressed.
“We need to moderate expectations. But we can’t moderate the expectations of the poor, if not the rich. We can’t ask the poor to sacrifice what the rich won’t.

“South Africa is once again at a moment of reckoning, where we are forced to make hard choices – in order to make the right choices.”


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept